Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications
- 22 October 2009
- journal article
- Published by Wiley in Transfusion
- Vol. 49 (11) , 2366-2373
Abstract
BACKGROUND: Conventional extracorporeal photopheresis (ECP) has proven efficacy for the treatment of several diseases but is limited to patients with sufficient body weight. A novel simplified mini buffy coat ECP technique that allows treatment of small children and patients with apheresis contraindications has been developed.STUDY DESIGN AND METHODS: White blood cell (WBC)‐rich buffy coat fractions were prepared from 5 to 8 mL/kg whole blood in a closed system, diluted, and ultraviolet A (UVA)‐irradiated after addition of 8‐methoxypsoralen (8‐MOP). Apoptosis and cell death were analyzed by annexin V and 7‐aminoactinomycin staining. Lymphocyte proliferation was measured after CD3/CD28 and phytohemagglutinin (PHA) stimulation. Autologous residual blood and UVA‐irradiated buffy coat were returned to the patients. Fifty‐six mini buffy coat ECP procedures were applied to three children with acute steroid‐refractory skin graft‐versus‐host disease and apheresis contraindications.RESULTS: Mean whole blood and buffy coat volumes were 166 (±61.8) and 8 (±1.6) mL, respectively, and resulted in a hematocrit of 2.2% (±0.4) after saline dilution (median ± SD). UVA irradiation of 8‐MOP buffy coat preparations resulted in significant induction of WBC apoptosis at 48‐72 hours (p ≤ 0.006). WBC proliferation was significantly inhibited both after CD3/CD28 stimulation and after PHA stimulation when compared to controls (p ≤ 0.001). No clinical or laboratory side effects were observed during mini ECP procedures and the three patients responded to the therapy.CONCLUSION: Mini buffy coat ECP induces apoptosis and lymphocyte proliferation inhibition, both of which occur after standard ECP. This study proposes that mini buffy coat ECP be used as a simple and inexpensive alternative to classical ECP in children and adult patients with apheresis contraindications.Keywords
This publication has 24 references indexed in Scilit:
- A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host diseaseBlood, 2008
- Photopheresis in pediatric graft‐versus‐host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literatureTransfusion, 2007
- Sanglifehrin A Blocks Key Dendritic Cell Functions In Vivo and Promotes Long-Term Allograft Survival Together with Low-Dose CsAAmerican Journal of Transplantation, 2007
- Technology Insight: ECP for the treatment of GvHD—can we offer selective immune control without generalized immunosuppression?Nature Clinical Practice Oncology, 2006
- Photopheresis in solid organ transplant rejectionJournal of Clinical Apheresis, 2006
- Rejection With Hemodynamic Compromise: Objective Evidence for Efficacy of PhotopheresisThe Journal of Heart and Lung Transplantation, 2006
- Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma GroupBritish Journal of Dermatology, 2005
- Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: A report of 3 casesTransfusion and Apheresis Science, 2005
- Mononuclear cell collection in patients undergoing extra‐corporeal photo‐chemotherapy for acute and chronic graft‐vs.‐host‐disease (GvHD): Comparison between COBE Spectra version 4.7 and 6.0 (AutoPBSC)Journal of Clinical Apheresis, 2002
- Clinical and mechanistic aspects of photopheresisJournal of Photochemistry and Photobiology B: Biology, 1997